Delivery Order SPE2DB22D9112-SPE2DB24FE6QB
Award Date 12/21/23
Potential Completion Date 12/22/23
Potential Value $4.3K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 120 capsules of the prescription medication XTANDI 40 MG. The order, valued at $4,311.35, was awarded on January 23, 2024 with a completion date of January 24, 2024. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that holds multiple contracts and delivery orders with DLA to supply a variety of pharmaceutical and medical...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 120 capsules of the pharmaceutical product XTANDI 40 MG. This order, valued at $34,490.80, has a completion date of December 27, 2023 and was awarded on December 26, 2023. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler that supplies a variety of brand-name and generic prescription drugs and medical products to DLA Troop...
- The U.S. Defense Logistics Agency awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 120 capsules of the pharmaceutical product XTANDI 40 MG. The $8,622.72 order has a completion date of January 17, 2024. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that holds various federal contracts to supply pharmaceuticals and medical products to support military treatment facilities worldwide. This delivery order is issued...
- The Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order to DMS Pharmaceutical Group Inc., a Woman Owned Small Business, to provide 120 capsules of the medication Xtandi 40 mg. The order has a completion date of January 18, 2024 and a potential value of $34,490.80. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that holds various federal contracts and Indefinite Delivery Vehicles (IDVs) to supply pharmaceuticals and medical products to military treatment...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of XTANDI 40 MG CAPSULE 120S. The contract, valued at $151,711.62, has a completion date of January 3, 2024. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler that provides a wide range of brand and generic prescription and over-the-counter drug supplies to the federal government, primarily the Department of Defense....
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the provision of XTANDI 40 mg capsules. The contract, valued at $25,868.10, has an ultimate completion date of May 6, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at up to $499,999,999, which allows the DLA to issue delivery...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide XTANDI 40 MG CAPSULE 120S. The contract has a completion date of January 8, 2024 and a potential value of $77,604.30. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that holds various federal contracts and Indefinite Delivery Vehicles (IDVs) to supply pharmaceuticals and medical products to the Department of Defense....
- The Defense Logistics Agency awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 120 capsules of the pharmaceutical product XTANDI 40 MG. The total potential value of this delivery order is $103,716.00. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler that holds various federal contracts and indefinite delivery vehicles to supply pharmaceuticals and medical products to the Department of Defense. This delivery...
- The Defense Logistics Agency Troop Support Medical has awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 120 capsules of the pharmaceutical product XTANDI 40 MG. This order has a completion date of January 10, 2024 and a potential value of $4,311.35. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler that holds various federal contracts and indefinite delivery vehicles to supply pharmaceuticals and medical...
- The Defense Logistics Agency awarded a firm fixed price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 120 capsules of the prescription drug XTANDI 40 mg for a potential value of $34,490.80. The contract has a completion date of January 24, 2024. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that holds various federal contracts and indefinite delivery vehicles to supply a wide range of pharmaceutical and medical products to...
- SPE2DB22D9112Indefinite Delivery Contract
- SPE2DB22D9112-SPE2DB24FE6QBDelivery Order
The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 120 capsules of the prescription medication XTANDI 40 MG. This order, valued at $4,311.35, will be fulfilled by December 22, 2023. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that holds various federal contracts and indefinite delivery vehicles to supply pharmaceuticals and medical products to the Department of Defense and military treatment facilities globally.
Generated 3/21/24, 9:54 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.3k | 12/21/23 |